Zeria Pharmaceutical Co Ltd
TSE:4559

Watchlist Manager
Zeria Pharmaceutical Co Ltd Logo
Zeria Pharmaceutical Co Ltd
TSE:4559
Watchlist
Price: 2 260 JPY 0.89% Market Closed
Market Cap: 99.6B JPY
Have any thoughts about
Zeria Pharmaceutical Co Ltd?
Write Note

Zeria Pharmaceutical Co Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zeria Pharmaceutical Co Ltd
Cash from Investing Activities Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Zeria Pharmaceutical Co Ltd
TSE:4559
Cash from Investing Activities
-ÂĄ4B
CAGR 3-Years
39%
CAGR 5-Years
-7%
CAGR 10-Years
-7%
Takeda Pharmaceutical Co Ltd
TSE:4502
Cash from Investing Activities
-ÂĄ354B
CAGR 3-Years
N/A
CAGR 5-Years
34%
CAGR 10-Years
-13%
Daiichi Sankyo Co Ltd
TSE:4568
Cash from Investing Activities
-ÂĄ65.7B
CAGR 3-Years
N/A
CAGR 5-Years
9%
CAGR 10-Years
3%
Otsuka Holdings Co Ltd
TSE:4578
Cash from Investing Activities
-ÂĄ295.4B
CAGR 3-Years
-71%
CAGR 5-Years
-34%
CAGR 10-Years
-11%
Chugai Pharmaceutical Co Ltd
TSE:4519
Cash from Investing Activities
-ÂĄ37.3B
CAGR 3-Years
36%
CAGR 5-Years
9%
CAGR 10-Years
-7%
Astellas Pharma Inc
TSE:4503
Cash from Investing Activities
-ÂĄ872.9B
CAGR 3-Years
-127%
CAGR 5-Years
-72%
CAGR 10-Years
-42%

See Also

What is Zeria Pharmaceutical Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-4B JPY

Based on the financial report for Jun 30, 2024, Zeria Pharmaceutical Co Ltd's Cash from Investing Activities amounts to -4B JPY.

What is Zeria Pharmaceutical Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-7%

Over the last year, the Cash from Investing Activities growth was -54%. The average annual Cash from Investing Activities growth rates for Zeria Pharmaceutical Co Ltd have been 39% over the past three years , -7% over the past five years , and -7% over the past ten years .

Back to Top